<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF
  xmlns:crm="http://www.cidoc-crm.org/rdfs/cidoc_crm_v5.0.2_english_label.rdfs#"
  xmlns:dc="http://purl.org/dc/elements/1.1/"
  xmlns:dcterms="http://purl.org/dc/terms/"
  xmlns:edm="http://www.europeana.eu/schemas/edm/"
  xmlns:foaf="http://xmlns.com/foaf/0.1/"
  xmlns:ore="http://www.openarchives.org/ore/terms/"
  xmlns:owl="http://www.w3.org/2002/07/owl#"
  xmlns:rdaGr2="http://rdvocab.info/ElementsGr2/"
  xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
  xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
  xmlns:skos="http://www.w3.org/2004/02/skos/core#"
  xmlns:svcs="http://rdfs.org/sioc/services#"
  xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:xalan="http://xml.apache.org/xalan">
  <edm:ProvidedCHO rdf:about="_3049">
    <dc:identifier>_3049</dc:identifier>
    <dc:title>BioCity Scotland are unable to open on Saturday 12th September 2015</dc:title>
    <dc:description>"&lt;p&gt; &lt;\/p&gt;&lt;p&gt;&lt;span style=&quot;font-family: Verdana, sans-serif; font-size: 7.5pt;&quot;&gt;Originally Organon which was founded by Dr. Saal van Zwanenberg in Oss, the Netherlands, in 1923 as Zwanenberg-Organon. Its first product was insulin in 1923.In the thirties it manufactured estrogens. In 1948, Organon acquired the Newhouse research site in Scotland, United Kingdom. The production of cortisone was initiated in 1953. The now named Koninklijke Zwanenberg-Organon (KZO) fused with the fibre producer AKU in 1969 to become AKZO, later Akzo Nobel.&lt;\/span&gt;&lt;\/p&gt;&lt;p&gt; &lt;\/p&gt;&lt;p&gt; &lt;\/p&gt;" </dc:description>
    <dc:type xml:lang="en">Organization</dc:type>
    <edm:currentLocation rdf:resource="#_3049_place_current"/>
                            <edm:type></edm:type>
  </edm:ProvidedCHO>

  <ore:Aggregation rdf:about="_3049#aggregation">
    <edm:aggregatedCHO rdf:resource="_3049"/>
    <edm:dataProvider></edm:dataProvider>
    <edm:provider></edm:provider>
    <edm:isShownBy rdf:resource="https://ddo.openvirtualworlds.org/uv/uv.html#?manifest=https://ddo.openvirtualworlds.org/galleries/manifest.php/3049"/>
    <edm:rights rdf:resource="https://creativecommons.org/licenses/by-sa/4.0/"/>
    <edm:object rdf:resource=""/>
  </ore:Aggregation>
  <edm:WebResource rdf:about="https://ddo.openvirtualworlds.org/uv/uv.html#?manifest=https://ddo.openvirtualworlds.org/galleries/manifest.php/3049">
      <dc:description>"&lt;p&gt; &lt;\/p&gt;&lt;p&gt;&lt;span style=&quot;font-family: Verdana, sans-serif; font-size: 7.5pt;&quot;&gt;Originally Organon which was founded by Dr. Saal van Zwanenberg in Oss, the Netherlands, in 1923 as Zwanenberg-Organon. Its first product was insulin in 1923.In the thirties it manufactured estrogens. In 1948, Organon acquired the Newhouse research site in Scotland, United Kingdom. The production of cortisone was initiated in 1953. The now named Koninklijke Zwanenberg-Organon (KZO) fused with the fibre producer AKU in 1969 to become AKZO, later Akzo Nobel.&lt;\/span&gt;&lt;\/p&gt;&lt;p&gt; &lt;\/p&gt;&lt;p&gt; &lt;\/p&gt;"</dc:description>
    <dc:format></dc:format>
    <edm:rights rdf:resource="https://creativecommons.org/licenses/by-sa/4.0/"/>
    <dc:type></dc:type>
  </edm:WebResource>
    <edm:Place rdf:about="#_3049_place_current">
        <wgs84_pos:lat>55.83541</wgs84_pos:lat>
        <wgs84_pos:long>-3.956086</wgs84_pos:long>
  </edm:Place>
</rdf:RDF>
 
